- Patent Title: HHLA2 as a novel inhibitor of human immune system and uses thereof
-
Application No.: US16121771Application Date: 2018-09-05
-
Publication No.: US11261253B2Publication Date: 2022-03-01
- Inventor: Xingxing Zang
- Applicant: ALBERT EINSTEIN COLLEGE OF MEDICINE
- Applicant Address: US NY Bronx
- Assignee: ALBERT EINSTEIN COLLEGE OF MEDICINE
- Current Assignee: ALBERT EINSTEIN COLLEGE OF MEDICINE
- Current Assignee Address: US NY Bronx
- Agency: Perkins Coie LLP
- Main IPC: C07K16/28
- IPC: C07K16/28
Abstract:
Provided are methods of treating an autoimmune disease in a subject, or of suppressing transplant rejection in a subject, or of treating a cancer in a subject, as well as compositions therefor.
Public/Granted literature
- US20190010234A1 HHLA2 AS A NOVEL INHIBITOR OF HUMAN IMMUNE SYSTEM AND USES THEREOF Public/Granted day:2019-01-10
Information query
